OneSource Specialty Pharma Schedules Board Meeting for Q2 FY27 Results
Onesource Specialty Pharma Ltd 路 Intimation 路 27 Oct 2026, 5:30 am
OneSource Specialty Pharma Schedules Board Meeting for Q2 FY27 Results OneSource Specialty Pharma Limited announced that its Board of Directors will meet on 27th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th Sep'26. In compliance with insider trading regulations, the trading window for designated persons has been closed since 1st Oct'26 and will reopen 48 hours following the public dissemination of the financial results.
Original exchange filing (PDF)
More announcements from Onesource Specialty Pharma Ltd
- Intimation of resignation of Senior Management Personnel 路 17 Nov 2026
- Onesource Specialty Pharma Limited has informed the Exchange about the Participation in Jefferies Global Healthcare Conference to be held from November 16, 2026 to November 19, 2026 in London. 路 05 Nov 2026
- Intimation of Transcript of Earnings call dated October 27, 2026 路 03 Nov 2026
- OneSource receives USFDA EIR with VAI Classification, Marking completion of Inspection process at its Sterile Product Division (SPD) Facility in Bengaluru. 路 30 Oct 2026
- Intimation of the Audio recording of the earnings call pertaining to the unaudited financial results for the quarter and half year ended September 30, 2026 路 28 Oct 2026
- OneSource announces strong Q2FY27, results revenue up 37% YoY and EBITDA up 53% YoY 路 27 Oct 2026
- Intimation of allotment of 360 equity shares of Re.1/- each under ONESOURCE ESOP 2021 on October 27, 2026. 路 27 Oct 2026
- Intimation of change in designation of Dr. Claudio Albrecht from Independent director to Non-Executive Non-Independent Director of the Company. 路 27 Oct 2026
